About CrystalGenomics
CrystalGenomics is a company based in Seongnam-si (South Korea) founded in 2000. The company has 80 employees as of December 31, 2024.
- Headquarter Seongnam-si, South Korea
- Employees 80 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cg Invites Co., Ltd.
-
Annual Revenue
$4.92 M (USD)48.67as on Dec 31, 2024
-
Net Profit
-$34.95 M (USD)-5.36as on Dec 31, 2024
-
EBITDA
-$23.46 M (USD)-13.22as on Dec 31, 2024
-
Latest Funding Round
$851.6 K (USD), Post-IPO
Dec 23, 2015
-
Investors
Ministry of Health and Welfare
& 1 more
-
Employee Count
80
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of CrystalGenomics
CrystalGenomics is a publicly listed company on the KRX with ticker symbol 083790 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of CrystalGenomics
Investors in CrystalGenomics
CrystalGenomics has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Ministry of Health and Welfare and Korea-Seoul Life Science Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Government entity responsible for health and welfare services in Taiwan.
|
Locked | Locked | Locked |
Investor details for CrystalGenomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CrystalGenomics
Investment portfolio details for CrystalGenomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CrystalGenomics
Detailed financials for CrystalGenomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Crystalgenomics Comparisons
Peer comparison for CrystalGenomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CrystalGenomics
Detailed competitors of CrystalGenomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Crystalgenomics
Complete news archive for CrystalGenomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CrystalGenomics
CrystalGenomics was founded in 2000 and raised its 1st funding round 12 years after it was founded.
CrystalGenomics is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.
As of Dec 31, 2024, the latest employee count at CrystalGenomics is 80.
Annual revenue of CrystalGenomics is $4.92M as on Dec 31, 2024.
Crystal Genomics is a clinical stage biopharmaceutical company working on the discovery and development of novel pharmaceuticals with innovative platform technologies to address significant unmet medical needs in the areas of infectious disease, oncology, and inflammatory diseases.The Companys lead therapeutic program is Accelex, a next-generation NSAID for osteoarthritis is in NDA approval phase. Other products include CG400549 the antibiotic for MRSA and CG200745, a molecular targeted cancer therapeutic for solid tumors are in phase 2 development. Another molecular targeted cancer therapeutic CG026806 is in pre-clinical trials. It acquired Hwail Pharmaceutical on August 14, 2013 and has partnered with Daewoong Pharmaceutical for Acelex Commercialization in Korea. It also offers platform technology for drug discovery.
Yes, CrystalGenomics is publicly traded on KRX under the ticker symbol 083790.
CrystalGenomics has 2 investors. Key investors include Ministry of Health and Welfare, and Korea-Seoul Life Science Fund.
The ticker symbol of CrystalGenomics is 083790 on KRX.